AI
Wednesday, October 05, 2022 6:56:36 PM
NVCR share holders aren’t buying your narrative. NVCR has a very dubious business outlook and future. Look at all the serious risks that they have buried in their SEC filing… it is no wonder that the share holders are heading for the exits. Novocure is down to a third of its share price since the peak just one year ago in June when it was over $200.
Look at all risks buried in their SEC filing on pages 25-51 of the document linked below. They have 26 pages of product efficacy risks, regulatory risks, legal risks, financial risks, market competition risks… etc etc. They admit under penalty of perjury that their company has serious risks.
You posted a million times about NWBO’s “SEC filings” but never say a word about the 25 pages of serious risks filed for same fiscal year for NVCR. Why not?
NVCR SEC Filing:
https://d18rn0p25nwr6d.cloudfront.net/CIK-0001645113/c5eca622-306f-417f-931b-c2ab018fa6b6.pdf#page25
Look at all risks buried in their SEC filing on pages 25-51 of the document linked below. They have 26 pages of product efficacy risks, regulatory risks, legal risks, financial risks, market competition risks… etc etc. They admit under penalty of perjury that their company has serious risks.
You posted a million times about NWBO’s “SEC filings” but never say a word about the 25 pages of serious risks filed for same fiscal year for NVCR. Why not?
NVCR SEC Filing:
https://d18rn0p25nwr6d.cloudfront.net/CIK-0001645113/c5eca622-306f-417f-931b-c2ab018fa6b6.pdf#page25
